| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |